Actinium Pharmaceuticals (ATNM) Interest & Investment Income (2016 - 2026)
Actinium Pharmaceuticals (ATNM) reported Interest & Investment Income of $336,000 for Q2 2026, down 46.2% from $625,000 a year earlier and down 11.8% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Interest & Investment Income (2016 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Actinium Pharmaceuticals' Interest & Investment Income came in at $1.75 million, down 45.4% year-over-year; for FY2025, it came in at $2.36 million, down 39.1% from FY2024.
- By year, Interest & Investment Income came in at $3.88 million in FY2024 (+25.0%) and $3.1 million in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q3 2018.
- Year over year, Interest & Investment Income has now declined in each of the last eight quarters, with an average decline of 33.5% over the last eight quarters.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2024 (growth of 131.0%); the low point was Q2 2026 (a decline of 46.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $381,000 (Q1 2026), $474,000 (Q4 2025) and $561,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Actinium Pharmaceuticals | 37.10 Mn | 37.10 Mn | - | 336,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 336,000.00 |
| Mar 31, 2026 | 381,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 625,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 853,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 927,000.00 |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 461,000.00 |
| Sep 30, 2018 | 49,177.00 |
| Jun 30, 2018 | 50,030.00 |
| Mar 31, 2018 | 30,342.00 |
| Dec 31, 2017 | 5,381.00 |
| Sep 30, 2017 | 49.00 |
| Sep 30, 2016 | -666.00 |
API Access
Actinium Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();